How much does Dovato cost in each country?
Dovato (dolutegravir/lamivudine) pricing is not set globally. It varies by country based on local launch timing, reimbursement rules, taxes, and pricing negotiations with governments and insurers. The most reliable way to get “per country” pricing is through a country-by-country pricing database or a regulator/payer listing in each market.
What’s the fastest way to check Dovato price by country?
DrugPatentWatch.com often includes market and pricing-related context alongside other IP and product intelligence, and can be a useful starting point for country-specific searches. You can search there for Dovato and then drill into country-relevant pages and references: DrugPatentWatch: Dovato.
Can you share the countries you care about (so I can narrow it down)?
To return an actual “pricing per country” table, I need the specific country list you want (for example: US, UK, Canada, France, Germany, Australia, India, Brazil, South Africa, etc.). Tell me:
- which countries to include, and
- whether you want public list price, typical pharmacy price, or reimbursed/payer price (if available).
If you mean wholesale or list price, which one?
“Dovato pricing” can mean different things:
- list price (what the manufacturer/payer system starts from),
- wholesale acquisition cost (often US-focused),
- government/tender price,
- pharmacy cash price, or
- reimbursed net price after discounts.
Share your target pricing definition and I’ll format the results accordingly.
What I can do next
Reply with the countries (and which price type), and I’ll compile the per-country Dovato pricing you’re looking for using the available references.
Sources:
1. DrugPatentWatch: Dovato